SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Extended search

WFRF:(Eto Takashi)
 

Search: WFRF:(Eto Takashi) > Journal article > Effects of DPP-4 in...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Yabe, DaisukeKobe university (author)

Effects of DPP-4 inhibitor linagliptin and GLP-1 receptor agonist liraglutide on physiological response to hypoglycaemia in Japanese subjects with type 2 diabetes : A randomized, open-label, 2-arm parallel comparative, exploratory trial

  • Article/chapterEnglish2017

Publisher, publication year, extent ...

  • 2016-11-29
  • Wiley,2017

Numbers

  • LIBRIS-ID:oai:lup.lub.lu.se:bba07c02-b3a6-457f-b691-61417c54ca63
  • https://lup.lub.lu.se/record/bba07c02-b3a6-457f-b691-61417c54ca63URI
  • https://doi.org/10.1111/dom.12817DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:art swepub-publicationtype
  • Subject category:ref swepub-contenttype

Notes

  • Dipeptidyl peptidase-4 (DPP-4) inhibitors reduce the risk of hypoglycaemia, possibly through augmentation of glucose-dependent insulinotropic polypeptide (GIP) action, but not that of glucagon-like peptide-1 (GLP-1) on glucagon secretion. To examine this model in Japanese individuals with type 2 diabetes (T2D), the effects of the DPP-4 inhibitor linagliptin on glucagon and other counter-regulatory hormone responses to hypoglycaemia were evaluated and compared with those of the GLP-1 receptor agonist liraglutide in a multi-centre, randomized, open-label, 2-arm parallel comparative, exploratory trial. Three-step hypoglycaemic clamp glucose tests preceded by meal tolerance tests were performed before and after 2-week treatment with the drugs. Glucagon levels were increased during the hypoglycaemic clamp test at 2.5mmol/L. This increase was similar in the linagliptin and liraglutide groups, both before and after the 2-week treatment. Changes in other counter-regulatory hormones (ie, growth hormone, cortisol, epinephrine and norepinephrine) were also similar between the groups, but were suppressed substantially after 2-week treatment compared to baseline. In conclusion, we confirmed that the glucagon response to hypoglycaemia was not affected by linagliptin or liraglutide treatment in Japanese individuals with T2D.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Eto, TakashiHakata Clinic (author)
  • Shiramoto, MasanariHakata Clinic (author)
  • Irie, ShinHakata Clinic (author)
  • Murotani, KentaAichi Medical University (author)
  • Seino, YusukeNagoya University (author)
  • Kuwata, HitoshiKansai Electric Power Medical Research Institute (KEPMRI) (author)
  • Kurose, TakeshiKansai Electric Power Medical Research Institute (KEPMRI) (author)
  • Seino, SusumuKobe university (author)
  • Ahrén, BoLund University,Lunds universitet,Medicin, Lund,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Medicine, Lund,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine(Swepub:lu)med-bah (author)
  • Seino, YutakaKansai Electric Power Medical Research Institute (KEPMRI) (author)
  • Kobe universityHakata Clinic (creator_code:org_t)

Related titles

  • In:Diabetes, Obesity and Metabolism: Wiley19:3, s. 442-4471462-8902

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view